---
figid: PMC8590697__41419_2021_4367_Fig7_HTML
figtitle: Graphical abstract of the mechanism by which cetuximab enhances RSL3-induced
  ferroptosis by inhibiting the Nrf2/HO-1 axis through the activation of p38 MAPK
organisms:
- Homo sapiens
- Mus musculus
- Ginkgo biloba
pmcid: PMC8590697
filename: 41419_2021_4367_Fig7_HTML.jpg
figlink: /pmc/articles/PMC8590697/figure/Fig7/
number: F7
caption: Cetuximab inhibited the Nrf2/HO-1 pathway via p38 MAPK activation and then
  regulated the sensitivity to RSL3 in KRAS mutant CRC cells.
papertitle: Cetuximab promotes RSL3-induced ferroptosis by suppressing the Nrf2/HO-1
  signalling pathway in KRAS mutant colorectal cancer.
reftext: Jiawen Yang, et al. Cell Death Dis. 2021 Nov;12(11):1079.
year: '2021'
doi: 10.1038/s41419-021-04367-3
journal_title: Cell Death & Disease
journal_nlm_ta: Cell Death Dis
publisher_name: Nature Publishing Group UK
keywords: Targeted therapies | Cell death
automl_pathway: 0.9472011
figid_alias: PMC8590697__F7
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
redirect_from: /figures/PMC8590697__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8590697__41419_2021_4367_Fig7_HTML.html
  '@type': Dataset
  description: Cetuximab inhibited the Nrf2/HO-1 pathway via p38 MAPK activation and
    then regulated the sensitivity to RSL3 in KRAS mutant CRC cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - EGFR
  - MMUT
  - KRAS
  - NRAS
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - CRK
  - AIMP2
  - GRAP2
  - AHSA1
  - POLDIP2
  - HMOX1
  - GABPA
  - NFE2L2
  - GPX4
  - Egf
  - Egfr
  - Mmut
  - Kras
  - Crk
  - Grap2
  - Syp
  - Mapk14
  - Ahsa1
  - Hmox1
  - Nfe2l2
  - Gpx4
  - Gpx4-ps2
---
